Does prior sepsis alter subsequent circadian and sickness behaviour response to lipopolysaccharide treatment in mice? by Anderson, Sean T. et al.
TRANSLATIONAL NEUROSCIENCES - ORIGINAL ARTICLE
Does prior sepsis alter subsequent circadian and sickness
behaviour response to lipopolysaccharide treatment in mice?
Sean T. Anderson • Emma K. O’Callaghan •
Sean Commins • Andrew N. Coogan
Received: 22 October 2013 / Accepted: 19 November 2013 / Published online: 15 December 2013
 Springer-Verlag Wien 2013
Abstract Previous data has shown that prior history of
immune challenge may affect central and behavioural
responses to subsequent immune challenge, either leading
to exaggerated responses via priming mechanisms or
lessened responses via endotoxin tolerance. In this set of
experiments we have examined how previously lipopoly-
saccharide (LPS)-induced sepsis shapes the response to
subsequent treatment with lower dose LPS. After treatment
with LPS (5 mg/kg) or saline mice were allowed to recover
for 3–4 months before being challenged with a lower dose
of LPS (100 lg/kg) for assessment of sickness behaviours.
Performance on the open field test and the tail suspension
test was assessed, and no evidence was found that prior
sepsis altered sickness or depressive-like behaviour fol-
lowing LPS treatment. We then examined the responsive-
ness of the circadian system of mice to LPS. We found that
in control animals, LPS induced a significant phase delay
of the behavioural rhythm and that this was not the case in
post-septic animals (4–6 weeks after sepsis), indicating
that prior sepsis alters the responsivity of the circadian
system to subsequent immune challenge. We further
assessed the induction of the immediate early genes c-Fos
and EGR1 in the hippocampus and the suprachiasmatic
nucleus (SCN; the master circadian pacemaker) by LPS in
control or post-septic animals, and found that post-septic
animals show elevated expression in the hippocampus but
not the SCN. These data suggest that previous sepsis has
some effect on behavioural and molecular responses to
subsequent immune challenge in mice.
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Introduction
Peripheral administration of the gram-negative bacterial
endotoxin lipopolysaccharide (LPS) has long been recog-
nised to produce a syndrome of behavioural changes
termed sickness behaviour, including decreased locomo-
tion and exploration, decreased food intake and increased
sleep, as well as inducing increased depressive-like
behaviours (McCusker and Kelley 2013). This behaviour
change may reflect an adaptive response to sickness that
best allows an organism to fight off infection (Dantzer
2001). It is believed that both peripheral neural activation
and production of humoral factors in response to the
immune challenge leads to induction of pro-inflammatory
mediators in the brain, and it is the action of these medi-
ators (e.g. TNF-a, IL-1b) that underpin the behavioural
changes elicited by immune challenge (Dantzer et al.
2008).
A homeostatic control system that may be of importance
in sickness behaviour is the circadian system (Coogan and
Wyse 2008). Circadian rhythms are recurring patterns in a
wide spectrum of physiological, endocrine, behavioural
and cognitive parameters that recur with periods of
approximately 24 h (Mohawk et al. 2012). The circadian
timekeeping network functions as a network of connected
central and peripheral oscillators, with what is thought of
as a master circadian pacemaker located to the suprach-
iasmatic nucleus (SCN) of the anterior hypothalamus
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(Dibner et al. 2010). The correct functioning of the circa-
dian system is increasingly being recognised as being a key
contributor to health and well being, and circadian dys-
function is linked with numerous metabolic, neurological
and psychiatric disorders (Bass and Takahashi 2010;
Coogan et al. 2013; McClung 2013). An area that may be
of importance in the modulation of the circadian system
during pathologies is the neuroimmune regulation of cen-
tral circadian pacemakers (Coogan and Wyse 2008).
Intriguingly, from a sickness behaviour point of view, there
is circadian control over the affected behavioural systems,
such as sleep, locomotor control and mood (McClung
2013; Coogan and Wyse 2008).
The nature of the behavioural response elicited by a
peripheral immune challenge may be determined by the
background against which that challenge is presented. For
example, LPS treatment of older animals produces exag-
gerated sickness behaviour response when compared to
younger animals (Henry et al. 2009). Further, ongoing
neuroinflammation and/or neurodegeneration ‘‘primes’’
behavioural and central responses to immune challenge,
and this may be an important mechanism in the patho-
physiology of delirium (Griffin et al. 2013; Cunningham
2013). Thus, previous neuroimmunological history may
impact behavioural responses to subsequent immune
challenge and central responsiveness to inflammatory
mediators, and these effects may be pertinent in a wide
range of clinical conditions. One such condition, of pro-
found clinical importance, is sepsis. Sepsis is a syndrome
characterised by systemic inflammation that is associated
with significant mortality (Angus and van der Poll 2013).
Survivors of sepsis have been described as exhibiting an
ongoing syndrome termed post-septic encephalopathy, in
which there are ongoing cognitive difficulties (Semmler
et al. 2013; Iwashyna et al. 2010). Similar findings of
changes in behavioural and cognitive parameters, that are
also accompanied by a chronic neuroinflammation, have
been described in animal models (Qin et al. 2007; We-
berpals et al. 2009; O’Callaghan et al. 2012). Given the
persistent upregulation of central inflammation following
sepsis, we set out to enquire whether prior sepsis would
impact on both behavioural and central molecular response
to peripheral LPS treatment.
Materials and methods
Animals
For the purpose of all experiments male C57BL/6 mice
(Charles River, Kent, UK) aged between 8 and 16 weeks
were used (N = 61 in total). Animals were group housed in
a 12:12 light:dark cycle for 2 weeks prior to LPS
administration. Food and water were available ad libitum
and temperature was 21 ± 1 C and humidity was
50 ± 10 %. Unless housed in isolation for circadian wheel
running experiments, animals remained housed in groups
of 2–4 in polypropylene cages (33 cm long 9 15 cm
wide 9 13 cm high) with wood chip bedding and envi-
ronmental enrichment (shredded paper and cardboard
tubes). All procedures were approved by the Research
Ethics Committee, National University of Ireland Mayno-
oth, and were licensed by the Department of Health and
Children, Ireland under statutory instrument (SI) No. 543
of 2012 and the European directive 2010/63/EU.
LPS-induced sepsis
All saline and LPS injections were made up fresh on the
treatment day, and given intraperitoneally in a final injec-
tion volume of 0.125 ml. 0.9 % sterile saline was made up
fresh for control injections, while LPS (serotype 0111.B4,
Sigma Ireland; Qin et al. 2007) was made up to a 5 mg/kg
dose in sterile saline. Injections were given intraperitone-
ally (i.p.) between zeitgeber time (ZT) 06 and 08, where
ZT0 is defined as the time of lights on. Animals were
allowed to recover for at least 1 month prior to behavioural
testing. Mortality and significant moribundity requiring
euthanasia occurred within approximately 7 % of animals
(N = 3) following the induction of sepsis.
Assessment of behaviour on the open field test
and the tail suspension test
Between 3 and 4 months after the septic LPS/saline treat-
ment, mice were treated in a counterbalanced fashion
(2 weeks between treatments) with either saline or LPS
(i.p; 100 lg/kg) injected at ZT2. Two hours after this
treatment animals were tested on the open field test (OFT)
and 9 h after treatment animals were tested on the tail
suspension test (TST), as depressive-like behaviours
develop over a longer period following peripheral LPS
treatment compared to sickness behaviour (Dantzer et al.
2008). For the OFT, testing occurred in an arena with a
diameter of 100 cm (light intensity of 200 lux in the centre
of the arena). The primary outcome of the OFT was to
assess sickness behaviour in terms of locomotor behaviour,
with anxiety related outcomes (time spent in centre vs. time
spent in the periphery) secondary endpoints. Each animal
was placed in the centre of the arena and allowed to
explore for 300 s during which their distance moved,
velocity in cm2 and time spent moving were automatically
tracked with Ethovision 3.1 software (Ethovision 3.1;
Noldus Information Technology, Leesburg, VA). The
percentage of time spent in the inner 50 % and outer 50 %
of the arena were also measured. For the TST, mice were
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removed from the home cage and attached to a support
raised 121 cm above a cage containing woodchip bedding
by tape placed 1 cm from the tip of their tales for 6 min.
Mice were suspended for 6 min each, with immobility
being recorded throughout the entire 6 min. Immobility
was defined as the complete absence of movement (Steru
et al. 1985).
Assessment of circadian rhythms in wheel running
behaviour
For the purpose of behavioural monitoring of circadian
rhythms, animals were individually housed in polypropyl-
ene cages (33 cm long 9 15 cm wide 9 13 cm high)
equipped with steel running wheels (11.5 cm diameter)
with food and water available ad libitum. The light source
was standard fluorescent light bulbs with an average 150
lux luminance level in each individual cage. Cages were
ventilated via axial fans to prevent the build-up of phero-
mones and these fans produced white noise at the level of
50 dB. In order to establish whether an altered behavioural
response would be seen in post-septic animals compared to
controls following a second immune challenge, 14 days
after induction of sepsis or control treatment (either 5 mg/
kg LPS or saline), animals were placed into constant
darkness (DD) for 14 days and allowed to free run. Ani-
mals then received either i.p. saline or an i.p. injection of
LPS at a dose of 100 lg/kg at CT15. This time was chosen
as it previously has been shown administration of low dose
LPS at this phase induces photic like phase delays of
locomotor activity (Marpega´n et al. 2005). Following
treatment, the animals were maintained in DD for an
additional 14 days before receiving a counterbalanced
treatment of either LPS or saline at CT15. Following this
treatment, the animals’ activity patterns in DD were fol-
lowed for 14 days and phase shifts of locomotor activity
rhythms assessed. The line of best fit method was used to
assess the phase shift magnitudes from the actogram data,
fitting the line through activity onsets 7 days before and
10 days after treatment with LPS 100 lg/kg or vehicle.
The differences between the lines from the actograms were
rated by two independent researchers blind to the experi-
mental procedure. Following each CT15 treatment, the
circadian parameters of free running period and rhythm
amplitude were calculated for each animal using the
Chronobiology Kit Chi Squared procedure.
Immediate early gene expression and markers
of microglia
In order to establish whether post-septic animals would
exhibit altered immediate early gene expression following
LPS treatment compared to controls, 6 week old male
mice were group housed in colonies of three in cages
equipped with appropriate environmental enrichment and
habituated to a 12:12 LD cycle for 2 weeks (150 lux,
lights on 0500 hours) prior to experimentation. The ani-
mals were treated with either LPS 5 mg/kg i.p. to induce
sepsis, or saline. The animals were allowed to recover
following the induction of sepsis and were maintained for
3–4 months under a 12:12 LD cycle. Both post-septic and
saline treated controls then received an i.p. injection of
LPS at a dose of 100 lg/kg at ZT1-2. Animals were then
terminally anaesthetized and perfused transcardially with
4 % paraformaldehyde. Animals were perfused 2, 4 or 9 h
after LPS treatment. Timepoints at 2 and 9 h were used
for assessment of immediate early gene expression, whilst
those at 4 h were used to assess microglial markers. We
examined 4 h as there has been reports of changes in
microglial function 4 h after LPS treatment (e.g. Chen
et al. 2008; Henry et al. 2009), and the 2 and 9 h time-
points to coincide with the times of behavioural testing.
We examined the hippocampus, as sickness behaviour has
been associated in a number of studies with neurochem-
ical changes in this brain region (e.g. Frenois et al. 2007)
and we examined the SCN given its profound importance
in circadian timekeeping (Dibner et al. 2010). Another
group of animals was treated with LPS 1 month after
sepsis treatment and sampled 4 h after LPS and these
animals’ brains were later used for the assessment of
microglial markers.
Following cryoprotection in 30 % sucrose brains were
coronally sectioned (30 lm sections) on a freezing sliding
stage microtome (Leica, Germany) and then sections pro-
cessed according to a standard avidin–biotin complex
nickel DAB immunohistochemical protocol (see Beynon
and Coogan 2010). All sections processed for the same
antigens were processed in parallel across experimental
groups. The primary antibodies used in this study were:
c-Fos, Santa Cruz Biotechnology (sc-52), rabbit poly-
clonal, used at 1:2,000; EGR1, Santa Cruz Biotechnology,
rabbit polyclonal (sc-189), 1:3,000; Cd-11b, ABD Serotec
(MCA74GA), rabbit polyclonal, used at 1:1,000; F4/80,
ABD Serotec (MCA497GA), rabbit polyclonal used at
1:100 and IL-1b Peprotech (500 P-51), rabbit polyclonal
used at 1:50.
Photomicrographs of hippocampus and SCN were taken
using a digital camera connected to an Olympus BX-51
light microscope equipped with an image analysis digital
system (ImageJ 1.43, NIH, USA). All images were taken
using the same camera and magnification settings. For
analysis, brain sections were examined under either the
109 or 409 objective lens. Between 3 and 6 bilateral
images were evaluated for each individual animal and
region depending on the area being examined and a mean
value obtained for each animal for each region. Only
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sections from the mid rostrocaudal level of the SCN were
examined (hence limiting the number of sections available
from any one animal) and for the hippocampus 4 to 6
bilateral sections per animal of the medial dorsoventral axis
of the hippocampus were analysed. Immunoreactive cells
in each region of interest were quantified using quantifi-
cation of immunoreactive (ir) cell number by an observer
by by-eye counting for the purpose of analysing immuno-
reactive nuclear staining for c-Fos and EGR1. The observer
was blinded to the experimental procedure during optical
density measurements or quantification of immunoreactive
cells. A previously described method for assessing glia
whereby the image was binarised for analysis was used for
integrated optical density measurements (Vilaplana and
Lavialle 1999) was used to assess staining levels for Cd-
11b, F4/80 and IL-1b.
Statistics
All data values given are mean ± SEM. Inferential sta-
tistical analysis was via factorial between groups or mixed
between-within groups ANOVAs and t tests as appropri-
ate (paired or independent). P\ 0.05 was deemed sta-
tistically significant. Where multiple comparisons were
carried out the appropriate Bonferroni correction was
applied.
Results
Mice tested on the OFT showed decreased exploration (as
assessed by time spent mobile, distance travelled and
velocity) following LPS treatment, irrespective of whether
they had previously undergone sepsis or not (Fig. 1a;
P\ 0.001 for each dependent variable for main effect of
acute LPS). However ANOVA reveals no significant sepsis
effect or sepsis 9 LPS interactions on measures of distance
travelled, time spent mobile or velocity for any of the
dependent variables analysed. When areas of the open field
explored were analysed we found there was a significant
difference in exploration of the periphery versus the centre,
with animals spending less time in the centre following
LPS than saline treatment (F1,14 = 7.4, P\ 0.05 for main
effect of acute LPS on time spent in the centre). However
there was no effect of prior sepsis nor a sepsis 9 LPS
treatment interaction (P = 0.31 and P = 0.39 respectively)
indicating that prior sepsis did not alter the extent to which
animals exploration of the open field was altered following
an acute peripheral LPS challenge. When examined on the
TST, both animals that had previously undergone sepsis
and those that had not showed increased immobility fol-
lowing LPS compared to saline treatment (F1,14 = 17,
P\ 0.001 for main effect of acute LPS treatment; Fig. 1c).
However there was no interaction effect of prior sepsis on
Fig. 1 Responses of post-septic and control mice on performance in
the open field and tail suspension tests. a Responses to both saline and
LPS treatment (100 lg/kg, i.p.) on locomotor parameters in the open
field test in both post-septic and control animals; b time spent
exploring the periphery and centre of the open field test after acute
LPS treatment in control and post-septic animals; c time spent
immobile on the tail suspension test following saline and LPS
treatment in control and post-septic animals. N = 7 for the post-septic
group and N = 9 for the control group. ***P\ 0.001, **P\ 0.01,
*P\ 0.05
S66 S. T. Anderson et al.
123
the immobility subsequently induced by LPS treatment
(P = 0.65) and pairwise comparisons indicate that LPS
induces significantly more immobility than saline treatment
in both control and post-septic animals. Therefore the
results from these experiments indicate that prior sepsis
does not affect behavioural responses to a 100 lg/kg
treatment of LPS as measured on the OFT and the TST.
We analysed immediate early gene expression at 2 and
9 h following LPS treatment in post-septic and control
animals. In the hippocampus there were significant main
effects of sepsis on c-Fos expression in the dentate gyrus
and the CA1 (F1,15 = 6.47, P\ 0.05 and F1,15 = 7.01,
P\ 0.05 respectively). Pairwise analysis reveals a signif-
icant upregulation of c-Fos in the dentate gyrus at 2 h in
post-septic animals and a decrease in the CA1 in post-
septic animals 9 h after LPS treatment (Fig. 2a, b). When
EGR-1 was examined, there was a main effect of sepsis on
EGR1 expression following acute LPS treatment in the
dentate gyrus and the CA1 (F1,15 = 7.7, P\ 0.05 and
F1,15 = 4.9, P\ 0.05 respectively). Pairwise analysis
reveals EGR1 expression at 2 h following LPS treatment in
the CA1 was enhanced in post-septic animals compared to
controls (Fig. 2c, d). We then examined microglial marker
expression in both post-septic (1 month after sepsis) and
control animals following a peripheral LPS challenge. In
the hippocampus we observed that expression of both Cd-
11b and F4/80 was higher in post-septic animals than in
controls (Fig. 3). When expression of the pro-inflammatory
cytokine IL-1b was examined there was no difference in its
expression in the hippocampus between post-septic animals
and controls following LPS treatment at either 2 or 9 h
(Fig. 4).
When tested for phase shifts of their circadian rhythms
in response to LPS treatment, animals that had previously
not undergone sepsis showed a moderate phase delay of the
free running rhythm after treatment with LPS at CT15
(-0.68 ± 0.14 h for LPS vs. -0.10 ± 0.07 h for saline
treatment; P\ 0.05; Fig. 5). There was no change in free
running period or rhythm power following LPS treatment,
nor any differences between the post-septic and control
groups (data not shown). For post-septic animals LPS
treatment did not elicit a significant phase shift compared
to control saline treatment (-0.22 ± 0.08 h for LPS trea-
ted animals compared to -0.25 ± 0.13 h for saline treat-
ment). ANOVA revealed a main effect for shift magnitude
elicited by the LPS (F1,20 = 6.79, P\ 0.05) and an
interaction effect for prior sepsis and acute LPS
(F1,20 = 8.65, P\ 0.01).
There were no differences in the expression of c-Fos or
EGR-1 in the SCN of post-septic animals compared to
controls following LPS treatment (Fig. 6) and further there
was also no difference in either Cd-11b or F4/80 expres-
sion after LPS treatment in the SCN of control and post-
septic animals (Fig. 7).
Fig. 2 Effect of prior sepsis on the expression of immediate early
gene products in the hippocampus of control and post-septic animals.
a and b Representative photomicrographs showing c-Fos and EGR1
immunostaining respectively in the hippocampus in control and post-
septic animals at 2 and 9 h after a LPS injection. N = 4–5 for each
group per timepoint. Scale bar 300 lm. c and d Quantification of
c-Fos and EGR1 immunostaining respectively in hippocampal
subfields at 2 and 9 h after acute LPS treatment. ***P\ 0.001,
**P\ 0.01, *P\ 0.05
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Discussion
This study explored how prior sepsis might impinge on
behavioural and molecular responses to subsequent immune
challenge. Previous studies to date have shown that in mice,
induction of sepsis with a 5 mg/kg dose of LPS induces a
long-lasting neuroinflammation (Qin et al. 2007; Weberpals
et al. 2009; O’Callaghan et al. 2012; Bossu` et al. 2012).
Further it has been reported that in animals who have
previously undergone sepsis that there are persistent changes
in neurophysiological, cognitive and behavioural parameters
(Calsavara et al. 2013; Iwashyna et al. 2010; Weberpals et al.
2009; O’Callaghan et al. 2012). These changes appear to
model the syndrome of post-septic encephalopathy in
patients who have survived sepsis and who display cognitive
impairments after discharge from hospital when compared to
patients who have spent similar durations in intensive care
wards due to other conditions (Semmler et al. 2013; Siami
Fig. 3 Expression of microglial
markers in the hippocampus
after LPS treatment of both
control and post-septic animals.
a Sample photomicrographs of
Cd-11b immunostaining and its
quantification in the
hippocampus 4 h after LPS
treatment in both control and
post-septic animals; b sample
photomicrographs of F4/80
immunostaining and its
quantification in the
hippocampus 4 h after LPS
treatment in both control and
post-septic animals. N = 7–8
pre group. Scale bars 300 lm.
*P\ 0.05
Fig. 4 Expression of IL-1b in the hippocampus following LPS
treatment of both control and post-septic animals. a Sample photo-
micrographs of IL-1b immunostaining in the hippocampus of control
and post-septic mice 2 and 9 h after LPS treatment. b Quantification
of IL-1b immunstaining in hippocampal subfields. N = 4 per group
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et al. 2008; Iwashyna et al. 2010). Animal studies of models
of neurodegeneration have indicated that the ongoing pro-
cess of neuronal cell death, coupled with concomitant
neuroinflammation, primes microglia for exaggerated
responses to peripheral immune challenge and leads to more
exacerbated behavioural and cognitive effects than would
normally be elicited by such an immune challenge against a
normal neuroimmunological background (reviewed by
Cunningham 2013). Further, immune challenge in healthy
older animals leads to an exaggerated behavioural response,
and aging in associated with increased neuroinflammation
(Norden and Godbout 2013). Therefore we set out to
examine whether the neuroinflammation observed post-
sepsis in the mouse might be associated with altered
responses to LPS.
The open field test is a mainstay of assessing sickness
behaviour that follows from peripheral immune challenge,
as it allows for motor activity and exploration to be
observed in the same task (Yirmiya et al. 1994). In our
study we found the expected suppression by LPS of loco-
motion and exploration in the OFT, although we found no
evidence that prior sepsis affected this. Further, as LPS
treatment induces a depressive-like state with a delayed
time course compared to sickness behaviour (Dantzer et al.
2008), we tested response to acute LPS on the TST, a well
validated model of behavioural despair (Cryan et al. 2005).
We observed the expected LPS-induced increase in
immobility, but again found no evidence for altered
responses to LPS in post-septic animals. It may be that
prior sepsis simply does not affect the behavioural
expression of subsequent LPS-induced behaviours, or it
may be that the acute LPS dose used in the current study
(100 lg/kg), which induces a mild to moderate sickness
behaviour (Cunningham et al. 2005) is not the optimal dose
Fig. 5 Circadian phase shifts in response to LPS treatment in control
and post-septic mice. Sample actograms from a a control and b a
post-septic animal showing the free running rhythm in DD before and
after challenge with both LPS (blue circle) and saline (green square).
The imposed lines show the lines of best fit through the activity onsets
prior to and after each treatment. c Shows the magnitude of the phase
delays elicited by both saline and LPS treatment at CT15 in control
and post-septic animals. N = 10 for the control group and N = 12 for
the post-septic group. *P\ 0.05
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to use, and that increased sensitivity to a lower dose of LPS
may be seen in post-septic animals; future experiments will
need to address such issues.
It is also interesting to note that whilst we observed no
behavioural impacts of prior sepsis on LPS-induced effects,
we did observe some changes in immediate early gene
expression, with significant changes in c-Fos and EGR1
expression observed in the hippocampus of post-septic
animals following acute LPS treatment compared to con-
trol non-sepsis animals treated with LPS. Previous data has
shown that forebrain c-Fos expression is induced by acute
LPS treatment in the mouse (Frenois et al. 2007) and EGR1
expression in the forebrain is also altered acutely by LPS
treatment (Bonow et al. 2009; Gavila´n et al. 2009). The
functional relevance of altered c-Fos and EGR1 expression
in the hippocampus after acute LPS treatment in post-septic
animals is unclear. EGR1 has been implicated as a plas-
ticity-associated mediator reported to be important in long-
term memory (Davis et al. 2003) and it will be of interest in
the future to assess acute LPS-induced effects on memory
formation and recall in behavioural tasks such as the
Morris water maze in post-septic animals, as acute LPS is
well described as inducing cognitive deficits in such tasks
(Shaw et al. 2001). An interesting precedent is found in the
expression of another plasticity-associated immediate early
gene product, ARC, whose expression in the dentate gyrus
is upregulated in a model of chronic neuroinflammation
involving ongoing central injection of LPS, with this
upregulation being associated with impaired performance
on spatial memory tasks (Hauss-Wegrzyniak et al. 1998;
Rosi et al. 2005). The changes in c-Fos and EGR1
expression in the post-septic animals may represent an
Fig. 6 Effect of prior sepsis on the expression of immediate early
gene products in the SCN of control and post-septic animals. a and
b Representative photomicrographs showing c-Fos and EGR1
immunostaining respectively in the SCN in control and post-septic
animals at 2 and 9 h after a LPS injection. N = 4–5 for each group
per timepoint. Scale bar 100 lm. c and d Quantification of c-Fos and
EGR1 immunostaining respectively in the SCN at 2 and 9 h after
acute LPS treatment
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increased central sensitivity to LPS-induced systematic
immunomediators (e.g. TNF-a, IL-1b), and it would be
interesting to test the behavioural and molecular responses
of post-septic animals not only to different doses of
peripheral LPS, but also to peripheral or central treatment
with mediators such as TNF-a and IL-1b.
For the analysis of circadian responses to acute LPS
treatment, we built on observations that peripheral LPS
treatment induces moderate phase delays of the free-run-
ning rhythm of locomotor behaviour, but only when LPS is
applied at CT15 (in the early portion of the activity phase;
Marpega´n et al. 2005). This effect of acute LPS is depen-
dent on TLR4 (Paladino et al. 2010) and involves the
central action of TNF-a (Leone et al. 2012). Further the
SCN has been shown to be sensitive to peripheral immune
challenge, with SCN levels of activated NF-jB p65, c-Fos
and EGR1 acutely-induced by peripheral LPS treatment
(Beynon and Coogan 2010; O’Callaghan et al. 2012).
Further we have previously described changes in circadian
clock resetting in post-septic animals (O’Callaghan et al.
2012). To our surprise we observed that treatment of post-
septic animals with acute LPS did not result in any sig-
nificant phase shift, in comparison to control animals who
displayed the expected phase delays. We do not believe
that there is an explanation offered for such findings in the
alteration of core circadian parameters in post-septic ani-
mals, as in the current studies and in previous studies
(O’Callaghan et al. 2012) we do not find alterations in free
running period, rhythm power or other core circadian
parameters. One possible explanation for the lack of effect
of acute LPS effects on the circadian system in post-septic
animals is the immunosuppression following from sepsis
(Hotchkiss et al. 2013) and/or from endotoxin tolerance
(Morris and Li 2012). Such effects seem somewhat unli-
kely, given that the timeframe between the septic LPS
treatment and the shortest time to the acute LPS treatment
is 4 weeks, by which time it would LPS-tolerance would be
expected to have dissipated (West and Heagy 2002). Fur-
ther, the results from the open field and tail suspension tests
indicate that LPS induces the same levels of behavioural
effects in post-septic animals as in controls, suggesting that
post-septic mice, at the time of testing used in our exper-
iments, are capable of producing appropriate behavioural
responses to further LPS challenge. Therefore it is not clear
as to the mechanisms by which there is an altered circadian
response to LPS in post-septic animals, and if this effect is
specific to the circadian system or is a secondary effect of a
more universal change. For example, Weberpals et al.
(2009) described changes in cerebral metabolism in post-
septic mice, and such changes may have an impact on the
response of the SCN to LPS. Further, loss of dendritic
spines has been described post-LPS in mice (Kondo et al.
2011), and such a loss might induce a functional rear-
rangement in the SCN and different characteristics of phase
Fig. 7 Expression of Cd-11b and F4/80 in the SCN following LPS
treatment of both control and post-septic mice. a Sample photomi-
crographs and b quantification of cd-11b and F4/80 immunostaining
4 h after LPS treatment in control and post-septic animals. N = 5–7
per group. Scale bar 100 lm
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resetting, as a previous study demonstrated altered resetting
in post-septic animals (O’Callaghan et al. 2012). There
were no apparent differences in the levels of c-Fos or
EGR1 in the SCN following on from an acute LPS treat-
ment in post-septic animals, although it should be noted
that for this analysis that LPS treatment occurred during the
subjective day, and not at CT15 which is the time of
treatment used to elicit behavioural phase shifts. We chose
this time of treatment as previous work had indicated that
acute LPS treatment during the subjective day can upreg-
ulate SCN expression of both c-Fos and EGR1 (Beynon
and Coogan 2010; O’Callaghan et al. 2012).
The analysis of the microglial markers F4/80 and Cd-11b
indicate that there is no difference in their expression in the
SCN following acute LPS treatment between post-septic and
control animals. However we do report a finding that levels
of both these antigens are elevated in the hippocampus fol-
lowing acute LPS treatment in post-septic animals. It may be
that microglia are more reactive to subsequent challenge in
post-septic animals, and that this effects is region-specific, or
it may reflect a general upregulation of microglial markers in
the post-septic hippocampus (e.g. Weberpals et al. 2009), or
a combination of the two. Our finding that hippocampal IL-
1b levels are not enhanced may be taken to indicate that
microglia are not more responsive, as priming experiments
have previously shown upregulation of IL-1b in microglia
following LPS treatment against a background of neurode-
generation (Cunningham et al. 2005).
Overall, this study indicates that prior LPS-induced
sepsis has some modality-specific effects on behavioural
response to subsequent immune challenge. Future work
may examine if prior sepsis alters performance on cogni-
tive and a broader range of behavioural tasks following
acute immune challenge in order to understand to what
extent exaggerated responses to subsequent infections may
contribute to the decrement of quality of life associated
with post-septic encephalopathy (Iwashyna et al. 2010).
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